Abstract
Summary
β-Cyclodextrin is a cyclic derivative of starch prepared from partially hydrolyzed starch (maltodextrin) by an enzymatic process.β-Cyclodextrin is a new type of pharmaceutical for raw materials and food additives, it can be widely used in medicine, food, cosmetics, the light industry, agriculture and other areas.
The global market for Beta-Cyclodextrin was estimated to be worth US$ 211.5 million in 2023 and is forecast to a readjusted size of US$ 247.4 million by 2030 with a CAGR of 2.3% during the forecast period 2024-2030
North American market for Beta-Cyclodextrin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Beta-Cyclodextrin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Beta-Cyclodextrin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Beta-Cyclodextrin include Roquette, Nihon Shokuhin Kako, Shandong Xinda, Zibo Qianhui, Mengzhou Huaxing, Mengzhou Hongji, Zhiyuan Biotechnology, Jiyan Chemicals And Pharmaceuticals and W＆Z Biotech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Beta-Cyclodextrin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Beta-Cyclodextrin by region & country, by Type, and by Application.
The Beta-Cyclodextrin market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Cyclodextrin.
Market Segmentation
By Company
Roquette
Nihon Shokuhin Kako
Shandong Xinda
Zibo Qianhui
Mengzhou Huaxing
Mengzhou Hongji
Zhiyuan Biotechnology
Jiyan Chemicals And Pharmaceuticals
W＆Z Biotech
Henrikang Biotech
Cyclo Therapeutics
Segment by Type:
97%(Purity)
98%(Purity)
99%(Purity)
Segment by Application
Food Industry
Pharmaceutical Industry
Cosmetics Industry
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Beta-Cyclodextrin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Beta-Cyclodextrin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Beta-Cyclodextrin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Beta-Cyclodextrin was estimated to be worth US$ 211.5 million in 2023 and is forecast to a readjusted size of US$ 247.4 million by 2030 with a CAGR of 2.3% during the forecast period 2024-2030
North American market for Beta-Cyclodextrin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Beta-Cyclodextrin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Beta-Cyclodextrin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Beta-Cyclodextrin include Roquette, Nihon Shokuhin Kako, Shandong Xinda, Zibo Qianhui, Mengzhou Huaxing, Mengzhou Hongji, Zhiyuan Biotechnology, Jiyan Chemicals And Pharmaceuticals and W＆Z Biotech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Beta-Cyclodextrin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Beta-Cyclodextrin by region & country, by Type, and by Application.
The Beta-Cyclodextrin market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Cyclodextrin.
Market Segmentation
By Company
Roquette
Nihon Shokuhin Kako
Shandong Xinda
Zibo Qianhui
Mengzhou Huaxing
Mengzhou Hongji
Zhiyuan Biotechnology
Jiyan Chemicals And Pharmaceuticals
W＆Z Biotech
Henrikang Biotech
Cyclo Therapeutics
Segment by Type:
97%(Purity)
98%(Purity)
99%(Purity)
Segment by Application
Food Industry
Pharmaceutical Industry
Cosmetics Industry
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Beta-Cyclodextrin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Beta-Cyclodextrin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Beta-Cyclodextrin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Beta-Cyclodextrin Product Introduction
1.2 Global Beta-Cyclodextrin Market Size Forecast
1.2.1 Global Beta-Cyclodextrin Sales Value (2019-2030)
1.2.2 Global Beta-Cyclodextrin Sales Volume (2019-2030)
1.2.3 Global Beta-Cyclodextrin Sales Price (2019-2030)
1.3 Beta-Cyclodextrin Market Trends & Drivers
1.3.1 Beta-Cyclodextrin Industry Trends
1.3.2 Beta-Cyclodextrin Market Drivers & Opportunity
1.3.3 Beta-Cyclodextrin Market Challenges
1.3.4 Beta-Cyclodextrin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Beta-Cyclodextrin Players Revenue Ranking (2023)
2.2 Global Beta-Cyclodextrin Revenue by Company (2019-2024)
2.3 Global Beta-Cyclodextrin Players Sales Volume Ranking (2023)
2.4 Global Beta-Cyclodextrin Sales Volume by Company Players (2019-2024)
2.5 Global Beta-Cyclodextrin Average Price by Company (2019-2024)
2.6 Key Manufacturers Beta-Cyclodextrin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Beta-Cyclodextrin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Beta-Cyclodextrin
2.9 Beta-Cyclodextrin Market Competitive Analysis
2.9.1 Beta-Cyclodextrin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Beta-Cyclodextrin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Cyclodextrin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 97%(Purity)
3.1.2 98%(Purity)
3.1.3 99%(Purity)
3.2 Global Beta-Cyclodextrin Sales Value by Type
3.2.1 Global Beta-Cyclodextrin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Beta-Cyclodextrin Sales Value, by Type (2019-2030)
3.2.3 Global Beta-Cyclodextrin Sales Value, by Type (%) (2019-2030)
3.3 Global Beta-Cyclodextrin Sales Volume by Type
3.3.1 Global Beta-Cyclodextrin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Beta-Cyclodextrin Sales Volume, by Type (2019-2030)
3.3.3 Global Beta-Cyclodextrin Sales Volume, by Type (%) (2019-2030)
3.4 Global Beta-Cyclodextrin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food Industry
4.1.2 Pharmaceutical Industry
4.1.3 Cosmetics Industry
4.2 Global Beta-Cyclodextrin Sales Value by Application
4.2.1 Global Beta-Cyclodextrin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Beta-Cyclodextrin Sales Value, by Application (2019-2030)
4.2.3 Global Beta-Cyclodextrin Sales Value, by Application (%) (2019-2030)
4.3 Global Beta-Cyclodextrin Sales Volume by Application
4.3.1 Global Beta-Cyclodextrin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Beta-Cyclodextrin Sales Volume, by Application (2019-2030)
4.3.3 Global Beta-Cyclodextrin Sales Volume, by Application (%) (2019-2030)
4.4 Global Beta-Cyclodextrin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Beta-Cyclodextrin Sales Value by Region
5.1.1 Global Beta-Cyclodextrin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Beta-Cyclodextrin Sales Value by Region (2019-2024)
5.1.3 Global Beta-Cyclodextrin Sales Value by Region (2025-2030)
5.1.4 Global Beta-Cyclodextrin Sales Value by Region (%), (2019-2030)
5.2 Global Beta-Cyclodextrin Sales Volume by Region
5.2.1 Global Beta-Cyclodextrin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Beta-Cyclodextrin Sales Volume by Region (2019-2024)
5.2.3 Global Beta-Cyclodextrin Sales Volume by Region (2025-2030)
5.2.4 Global Beta-Cyclodextrin Sales Volume by Region (%), (2019-2030)
5.3 Global Beta-Cyclodextrin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Beta-Cyclodextrin Sales Value, 2019-2030
5.4.2 North America Beta-Cyclodextrin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Beta-Cyclodextrin Sales Value, 2019-2030
5.5.2 Europe Beta-Cyclodextrin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Beta-Cyclodextrin Sales Value, 2019-2030
5.6.2 Asia Pacific Beta-Cyclodextrin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Beta-Cyclodextrin Sales Value, 2019-2030
5.7.2 South America Beta-Cyclodextrin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Beta-Cyclodextrin Sales Value, 2019-2030
5.8.2 Middle East & Africa Beta-Cyclodextrin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Beta-Cyclodextrin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Beta-Cyclodextrin Sales Value
6.2.1 Key Countries/Regions Beta-Cyclodextrin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Beta-Cyclodextrin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Beta-Cyclodextrin Sales Value, 2019-2030
6.3.2 United States Beta-Cyclodextrin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Beta-Cyclodextrin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Beta-Cyclodextrin Sales Value, 2019-2030
6.4.2 Europe Beta-Cyclodextrin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Beta-Cyclodextrin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Beta-Cyclodextrin Sales Value, 2019-2030
6.5.2 China Beta-Cyclodextrin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Beta-Cyclodextrin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Beta-Cyclodextrin Sales Value, 2019-2030
6.6.2 Japan Beta-Cyclodextrin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Beta-Cyclodextrin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Beta-Cyclodextrin Sales Value, 2019-2030
6.7.2 South Korea Beta-Cyclodextrin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Beta-Cyclodextrin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Beta-Cyclodextrin Sales Value, 2019-2030
6.8.2 Southeast Asia Beta-Cyclodextrin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Beta-Cyclodextrin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Beta-Cyclodextrin Sales Value, 2019-2030
6.9.2 India Beta-Cyclodextrin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Beta-Cyclodextrin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roquette
7.1.1 Roquette Company Information
7.1.2 Roquette Introduction and Business Overview
7.1.3 Roquette Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roquette Beta-Cyclodextrin Product Offerings
7.1.5 Roquette Recent Development
7.2 Nihon Shokuhin Kako
7.2.1 Nihon Shokuhin Kako Company Information
7.2.2 Nihon Shokuhin Kako Introduction and Business Overview
7.2.3 Nihon Shokuhin Kako Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Nihon Shokuhin Kako Beta-Cyclodextrin Product Offerings
7.2.5 Nihon Shokuhin Kako Recent Development
7.3 Shandong Xinda
7.3.1 Shandong Xinda Company Information
7.3.2 Shandong Xinda Introduction and Business Overview
7.3.3 Shandong Xinda Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shandong Xinda Beta-Cyclodextrin Product Offerings
7.3.5 Shandong Xinda Recent Development
7.4 Zibo Qianhui
7.4.1 Zibo Qianhui Company Information
7.4.2 Zibo Qianhui Introduction and Business Overview
7.4.3 Zibo Qianhui Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zibo Qianhui Beta-Cyclodextrin Product Offerings
7.4.5 Zibo Qianhui Recent Development
7.5 Mengzhou Huaxing
7.5.1 Mengzhou Huaxing Company Information
7.5.2 Mengzhou Huaxing Introduction and Business Overview
7.5.3 Mengzhou Huaxing Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Mengzhou Huaxing Beta-Cyclodextrin Product Offerings
7.5.5 Mengzhou Huaxing Recent Development
7.6 Mengzhou Hongji
7.6.1 Mengzhou Hongji Company Information
7.6.2 Mengzhou Hongji Introduction and Business Overview
7.6.3 Mengzhou Hongji Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mengzhou Hongji Beta-Cyclodextrin Product Offerings
7.6.5 Mengzhou Hongji Recent Development
7.7 Zhiyuan Biotechnology
7.7.1 Zhiyuan Biotechnology Company Information
7.7.2 Zhiyuan Biotechnology Introduction and Business Overview
7.7.3 Zhiyuan Biotechnology Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Zhiyuan Biotechnology Beta-Cyclodextrin Product Offerings
7.7.5 Zhiyuan Biotechnology Recent Development
7.8 Jiyan Chemicals And Pharmaceuticals
7.8.1 Jiyan Chemicals And Pharmaceuticals Company Information
7.8.2 Jiyan Chemicals And Pharmaceuticals Introduction and Business Overview
7.8.3 Jiyan Chemicals And Pharmaceuticals Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jiyan Chemicals And Pharmaceuticals Beta-Cyclodextrin Product Offerings
7.8.5 Jiyan Chemicals And Pharmaceuticals Recent Development
7.9 W＆Z Biotech
7.9.1 W＆Z Biotech Company Information
7.9.2 W＆Z Biotech Introduction and Business Overview
7.9.3 W＆Z Biotech Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 W＆Z Biotech Beta-Cyclodextrin Product Offerings
7.9.5 W＆Z Biotech Recent Development
7.10 Henrikang Biotech
7.10.1 Henrikang Biotech Company Information
7.10.2 Henrikang Biotech Introduction and Business Overview
7.10.3 Henrikang Biotech Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Henrikang Biotech Beta-Cyclodextrin Product Offerings
7.10.5 Henrikang Biotech Recent Development
7.11 Cyclo Therapeutics
7.11.1 Cyclo Therapeutics Company Information
7.11.2 Cyclo Therapeutics Introduction and Business Overview
7.11.3 Cyclo Therapeutics Beta-Cyclodextrin Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Cyclo Therapeutics Beta-Cyclodextrin Product Offerings
7.11.5 Cyclo Therapeutics Recent Development
8 Industry Chain Analysis
8.1 Beta-Cyclodextrin Industrial Chain
8.2 Beta-Cyclodextrin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Beta-Cyclodextrin Sales Model
8.5.2 Sales Channel
8.5.3 Beta-Cyclodextrin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer